TY - JOUR AU - Schon, M. AU - Boeknck, W. H. PY - 2005 DA - 2005// TI - Psoriasis JO - NEJM VL - 352 UR - https://doi.org/10.1056/NEJMra041320 DO - 10.1056/NEJMra041320 ID - Schon2005 ER - TY - JOUR AU - Gladman, D. D. PY - 1998 DA - 1998// TI - Psoriatic arthritis JO - Rheum Dis Clin North Am VL - 24 UR - https://doi.org/10.1016/S0889-857X(05)70044-2 DO - 10.1016/S0889-857X(05)70044-2 ID - Gladman1998 ER - TY - JOUR AU - Lawrence, R. C. AU - Hochberg, M. C. AU - Kelsey, J. L. PY - 1989 DA - 1989// TI - Estimate of the prevalence of selected arthritis and musculoskeletal diseases in the United States JO - J Rheumatol VL - 16 ID - Lawrence1989 ER - TY - JOUR AU - Gladman, D. D. AU - Farewell, V. T. AU - Nadeau, C. PY - 1995 DA - 1995// TI - Clinical indicators of progression in psoriatic arthritis: multivariate relative risk mode JO - J Rheumatol VL - 22 ID - Gladman1995 ER - TY - JOUR AU - Little, H. AU - Harvie, J. N. AU - Lester, R. S. PY - 1975 DA - 1975// TI - Psoriatic arthritis in severe psoriasis JO - Can Med Assoc J VL - 112 ID - Little1975 ER - TY - JOUR AU - Leonard, D. G. AU - O'Duffy, J. D. AU - Rogers, R. S. PY - 1978 DA - 1978// TI - Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis JO - Mayo Clin Proc VL - 53 ID - Leonard1978 ER - TY - JOUR AU - Elkayam, O. AU - Ophir, J. AU - Yaron, M. AU - Caspi, D. PY - 2000 DA - 2000// TI - Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution JO - Clin Rheumatol VL - 19 UR - https://doi.org/10.1007/PL00011173 DO - 10.1007/PL00011173 ID - Elkayam2000 ER - TY - JOUR AU - Gladman, D. D. AU - Anhorn, K. A. B. AU - Schachter, R. K. AU - Mervart, H. PY - 1986 DA - 1986// TI - HLA antigens in psoriatic arthritis JO - J Rheumatol VL - 13 ID - Gladman1986 ER - TY - JOUR AU - Gladman, D. D. AU - Shuckett, R. AU - Russell, M. L. AU - Thorne, J. C. AU - Schachter, R. K. PY - 1987 DA - 1987// TI - Psoriatic arthritis – an analysis of 220 patients JO - Quart J Med VL - 62 ID - Gladman1987 ER - TY - CHAP AU - Espinoza, L. R. ED - Gerber, L. H. ED - Espinoza PY - 1985 DA - 1985// TI - Psoriatic arthritis: further epidemiologic and genetic consideration BT - Psoriatic arthritis PB - Stratton CY - Orlando Florida ID - Espinoza1985 ER - TY - JOUR AU - Sakkas, L. I. AU - Loqueman, N. AU - Bird, H. AU - Vaughan, R. W. AU - Welsh, K. I. AU - Panayi, G. S. PY - 1990 DA - 1990// TI - HLA class II and T cell receptor gene polymorphisms in psoriatic arthritis and psoriasis JO - J Rheumatol VL - 17 ID - Sakkas1990 ER - TY - JOUR AU - Eastmon, C. J. PY - 1994 DA - 1994// TI - Psoriatic arthritis. Genetics and HLA antigens JO - Baillieres Clin Rheumatol VL - 8 UR - https://doi.org/10.1016/S0950-3579(94)80018-9 DO - 10.1016/S0950-3579(94)80018-9 ID - Eastmon1994 ER - TY - JOUR AU - Tomfohrde, J. AU - Silverman, A. AU - Barnes, R. PY - 1994 DA - 1994// TI - Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q JO - Science VL - 264 UR - https://doi.org/10.1126/science.8178173 DO - 10.1126/science.8178173 ID - Tomfohrde1994 ER - TY - JOUR AU - Matthews, D. AU - Fry, L. AU - Powels, A. PY - 1996 DA - 1996// TI - Evidence that a locus for familial psoriasis maps to chromosome 4q JO - Nat Genet VL - 13 UR - https://doi.org/10.1038/ng1096-231 DO - 10.1038/ng1096-231 ID - Matthews1996 ER - TY - JOUR AU - Burden, A. AU - Javed, S. AU - Bailey, M. PY - 1998 DA - 1998// TI - Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p JO - J Invest Dermatol VL - 110 UR - https://doi.org/10.1046/j.1523-1747.1998.00213.x DO - 10.1046/j.1523-1747.1998.00213.x ID - Burden1998 ER - TY - JOUR AU - Veal, C. D. AU - Clough, R. L. AU - Barber, R. C. PY - 2001 DA - 2001// TI - Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci JO - J Med Genet VL - 38 UR - https://doi.org/10.1136/jmg.38.1.7 DO - 10.1136/jmg.38.1.7 ID - Veal2001 ER - TY - JOUR AU - Hohler, T. AU - Kruger, A. AU - Schneider, P. M. PY - 1997 DA - 1997// TI - A TNF-α promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis JO - J Invest Dermatol VL - 109 UR - https://doi.org/10.1111/1523-1747.ep12337469 DO - 10.1111/1523-1747.ep12337469 ID - Hohler1997 ER - TY - JOUR AU - Balding, J. AU - Kane, D. AU - Lingstone, W. AU - Mynett-Johnson, L. AU - Bresnihan, B. AU - Smith, O. AU - FitzGerald, O. PY - 2003 DA - 2003// TI - Cytokine Gene Polymorphisms: Associations with Psoriatic Arthritis Susceptibility and Severity JO - Arth & Rheum VL - 48 UR - https://doi.org/10.1002/art.10935 DO - 10.1002/art.10935 ID - Balding2003 ER - TY - JOUR AU - Rahman, P. AU - Siannis, F. AU - Butt, C. AU - Farewell, V. AU - Peddle, L. AU - Pellet, F. AU - Gladman, D. PY - 2005 DA - 2005// TI - Meta-Analysis of TNF-Alpha Polymorphisms in Caucasian Psoriatic Arthritis Populations JO - Ann Rheum Dis VL - 64 ID - Rahman2005 ER - TY - JOUR AU - Gonzalez, S. AU - Martinez-Borra, J. AU - Lopez-Vazquez, A. PY - 2002 DA - 2002// TI - MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis JO - J Rheumatol VL - 29 ID - Gonzalez2002 ER - TY - CHAP AU - Vasey, F. B. ED - Gerber, L. H. ED - Espinoza PY - 1985 DA - 1985// TI - Etiology and pathogenesis of psoriatic arthritis BT - Psoriatic arthritis PB - Stratton CY - Orlando Florida ID - Vasey1985 ER - TY - JOUR AU - Vasey, F. B. AU - Deitz, C. AU - Fenske, N. A. PY - 1982 DA - 1982// TI - Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis JO - J Rheumatol VL - 9 ID - Vasey1982 ER - TY - JOUR AU - Njobvu, P. AU - McGill, P. PY - 2000 DA - 2000// TI - Psoriatic arthritis and human immunodeficiency virus infection in Zambia JO - J Rheumatol VL - 27 ID - Njobvu2000 ER - TY - JOUR AU - Taglione, E. V. AU - Martini, M. L. AU - Galluzzo, P. PY - 1999 DA - 1999// TI - Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis JO - J Rheumatol VL - 26 ID - Taglione1999 ER - TY - JOUR AU - Panayi, G. PY - 1994 DA - 1994// TI - Immunology of psoriasis and psoriatic arthritis JO - Baillieres Clin Rheumatol VL - 8 UR - https://doi.org/10.1016/S0950-3579(94)80026-X DO - 10.1016/S0950-3579(94)80026-X ID - Panayi1994 ER - TY - JOUR AU - Veale, D. J. AU - Barnes, L. AU - Rogers, S. AU - Fitzgerald, O. PY - 1994 DA - 1994// TI - Immunohistochemical markers for arthritis in psoriasis JO - Ann Rheum Dis VL - 53 UR - https://doi.org/10.1136/ard.53.7.450 DO - 10.1136/ard.53.7.450 ID - Veale1994 ER - TY - JOUR AU - Costello, P. J. AU - Winchester, R. J. AU - Curran, S. A. PY - 2001 DA - 2001// TI - Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions that appear antigen driven JO - J Immunol VL - 166 UR - https://doi.org/10.4049/jimmunol.166.4.2878 DO - 10.4049/jimmunol.166.4.2878 ID - Costello2001 ER - TY - JOUR AU - Laloux, L. AU - Voisin, M. C. AU - Allain, J. PY - 2001 DA - 2001// TI - Immunohistological study of enthesis in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis JO - Ann Rheum Dis VL - 60 UR - https://doi.org/10.1136/ard.60.4.316 DO - 10.1136/ard.60.4.316 ID - Laloux2001 ER - TY - JOUR AU - Tassiulas, I. AU - Duncan, S. R. AU - Centola, M. PY - 1999 DA - 1999// TI - Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis JO - Hum Immunol VL - 60 UR - https://doi.org/10.1016/S0198-8859(99)00034-8 DO - 10.1016/S0198-8859(99)00034-8 ID - Tassiulas1999 ER - TY - JOUR AU - Ritchlin, C. AU - Haas-Smith, S. A. AU - Hicks, D. PY - 1998 DA - 1998// TI - Patterns of cytokine production in psoriatic synovium JO - J Rheumatol VL - 25 ID - Ritchlin1998 ER - TY - JOUR AU - Danning, C. L. AU - Illei, G. G. AU - Hitchon, C. PY - 2000 DA - 2000// TI - Macrophage-derived cytokine and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis JO - Arthritis Rheum VL - 43 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Danning2000 ER - TY - JOUR AU - Saklatvala, J. PY - 1986 DA - 1986// TI - Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage JO - Nature VL - 322 UR - https://doi.org/10.1038/322547a0 DO - 10.1038/322547a0 ID - Saklatvala1986 ER - TY - JOUR AU - Bertolini, D. R. AU - Nedwin, G. E. AU - Bringman, T. S. PY - 1986 DA - 1986// TI - Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors JO - Nature VL - 319 UR - https://doi.org/10.1038/319516a0 DO - 10.1038/319516a0 ID - Bertolini1986 ER - TY - JOUR AU - Ettehadi, P. AU - Greaves, M. W. AU - Wallach, D. PY - 1994 DA - 1994// TI - Elevated tumor necrosis factor alpha biological activity in psoriatic skin lesions JO - Clin Exp Immunol VL - 96 UR - https://doi.org/10.1111/j.1365-2249.1994.tb06244.x DO - 10.1111/j.1365-2249.1994.tb06244.x ID - Ettehadi1994 ER - TY - JOUR AU - Fearon, U. AU - Reece, R. AU - Smith, J. PY - 1999 DA - 1999// TI - Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients JO - Ann N Y Acad Sci VL - 878 UR - https://doi.org/10.1111/j.1749-6632.1999.tb07743.x DO - 10.1111/j.1749-6632.1999.tb07743.x ID - Fearon1999 ER - TY - JOUR AU - Pitzalis, C. AU - Cauli, A. AU - Pipitone, N. PY - 1996 DA - 1996// TI - Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780390118 DO - 10.1002/art.1780390118 ID - Pitzalis1996 ER - TY - JOUR AU - McHugh, N. J. AU - Balachrishnan, C. AU - Jones, S. M. PY - 2003 DA - 2003// TI - Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study JO - Rheumatology VL - 42 UR - https://doi.org/10.1093/rheumatology/keg217 DO - 10.1093/rheumatology/keg217 ID - McHugh2003 ER - TY - CHAP AU - Resnick, D. AU - Niwayama, G. PY - 1981 DA - 1981// TI - Psoriatic arthritis BT - Diagnosis of bone joint disorders PB - WB Saunder Co CY - Philadelphia ID - Resnick1981 ER - TY - JOUR AU - Gladman, D. D. AU - Shuckett, R. AU - Russell, M. L. PY - 1987 DA - 1987// TI - Psoriatic arthritis – an analysis of 220 patients JO - Quart J Med VL - 62 ID - Gladman1987 ER - TY - JOUR AU - Jones, S. M. AU - Armas, J. B. AU - Cohen, M. G. PY - 1994 DA - 1994// TI - Psoriatic arthritis: Outcome of disease subsets and relationship of joint disease to nail and skin disease JO - Br J Rheumatol VL - 33 UR - https://doi.org/10.1093/rheumatology/33.9.834 DO - 10.1093/rheumatology/33.9.834 ID - Jones1994 ER - TY - STD TI - Kane D, Stafford L, Bresnihan B, Fitzgerald O: A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology. 2003 Oct 1, ID - ref41 ER - TY - JOUR AU - Pringle, F. PY - 1999 DA - 1999// TI - A multidisciplinary approach to psoriatic arthropathy JO - Community Nurse VL - 5 ID - Pringle1999 ER - TY - JOUR AU - Gladman, D. D. AU - Farewell, V. T. AU - Wong, K. AU - Husted, J. PY - 1998 DA - 1998// TI - Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death JO - Arthritis Rheum VL - 41 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Gladman1998 ER - TY - CHAP AU - Christophers, E. AU - Mrowietz, U. ED - Freedberg, I. M. ED - Eisen, A. Z. ED - Wolff, K. PY - 1999 DA - 1999// TI - Psoriasis BT - Fitzpatrick's Dermatology in General Medicine PB - McGraw Hill CY - New York ID - Christophers1999 ER - TY - JOUR AU - Black, R. L. AU - O'Brian, W. M. AU - Van Scott, E. J. PY - 1964 DA - 1964// TI - Methotrexate therapy in psoriatic arthritis: double-blind study on 21 patients JO - JAMA VL - 189 UR - https://doi.org/10.1001/jama.1964.03070100037007 DO - 10.1001/jama.1964.03070100037007 ID - Black1964 ER - TY - JOUR AU - Willkens, R. F. AU - Williams, H. J. AU - Ward, J. R. PY - 1984 DA - 1984// TI - Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis JO - Arthritis Rheum VL - 27 UR - https://doi.org/10.1002/art.1780270403 DO - 10.1002/art.1780270403 ID - Willkens1984 ER - TY - JOUR AU - Marquerie, L. AU - Flipo, R. M. AU - Grardel, B. PY - 2002 DA - 2002// TI - Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis JO - Joint bone spine VL - 69 UR - https://doi.org/10.1016/S1297-319X(02)00396-2 DO - 10.1016/S1297-319X(02)00396-2 ID - Marquerie2002 ER - TY - JOUR AU - Spadaro, A. AU - Taccari, E. AU - Mohtadi, B. PY - 1997 DA - 1997// TI - Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs JO - Clin Exp Rheumatol VL - 15 ID - Spadaro1997 ER - TY - JOUR AU - Kaltwasser, J. P. AU - Nash, P. AU - Gladman, D. AU - Rosen, C. F. AU - Behrens, F. AU - Jones, P. AU - Wollenhaupt, J. AU - Falk, F. AU - Mease, P. PY - 2004 DA - 2004// TI - Efficacy and Safety of Leflunomide in the Treatment of Psoriatic Arthritis and Psoriasis: A Multinational, Double Blind, Randomized, Placebo Controlled Clinical Trial JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20253 DO - 10.1002/art.20253 ID - Kaltwasser2004 ER - TY - JOUR AU - Clegg, D. O. AU - Reda, D. J. AU - Mejias, E. PY - 1996 DA - 1996// TI - Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780391210 DO - 10.1002/art.1780391210 ID - Clegg1996 ER - TY - JOUR AU - Ellis, C. N. AU - Fradin, M. S. AU - Messana, J. M. PY - 1991 DA - 1991// TI - Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199101313240501 DO - 10.1056/NEJM199101313240501 ID - Ellis1991 ER - TY - JOUR AU - Braun, J. AU - Sieper, J. PY - 2003 DA - 2003// TI - Role of novel biological therapies in psoriatic arthritis JO - Biodrugs VL - 17 UR - https://doi.org/10.2165/00063030-200317030-00005 DO - 10.2165/00063030-200317030-00005 ID - Braun2003 ER - TY - JOUR AU - Kavanaugh, A. AU - Cohen, S. AU - Cush, J. PY - 2004 DA - 2004// TI - The evolving use of TNF inhibitors in rheumatoid arthritis JO - J Rheumatol VL - 31 ID - Kavanaugh2004 ER - TY - JOUR AU - Moreland, L. W. AU - Cohen, S. B. AU - Baumgartner, S. W. PY - 2001 DA - 2001// TI - Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis JO - J Rheumatol VL - 28 ID - Moreland2001 ER - TY - JOUR AU - Bondeson, J. AU - Maini, R. N. PY - 2001 DA - 2001// TI - Tumor necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE) JO - Int J Clin Pract VL - 55 ID - Bondeson2001 ER - TY - JOUR AU - Mease, P. AU - Goffe, B. S. AU - Metz, J. PY - 2000 DA - 2000// TI - Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02530-7 DO - 10.1016/S0140-6736(00)02530-7 ID - Mease2000 ER - TY - JOUR AU - Mease, P. AU - Kivitz, A. AU - Burch, F. PY - 2001 DA - 2001// TI - Improvement in disease activity in patients with psoriatic arthritis receiving etanercept (Enbrel): results of a phase 3 multicenter clinical trial (abstract) JO - Arthritis Rheum VL - 44 ID - Mease2001 ER - TY - JOUR AU - Clegg, D. O. AU - Reda, D. J. AU - Mejias, E. PY - 1996 DA - 1996// TI - Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780391210 DO - 10.1002/art.1780391210 ID - Clegg1996 ER - TY - JOUR AU - Felson, D. T. AU - Andersen, J. J. AU - Boers, M. PY - 1995 DA - 1995// TI - American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380602 DO - 10.1002/art.1780380602 ID - Felson1995 ER - TY - JOUR AU - Mease, P. J. AU - Goffe, B. S. AU - Metz, J. PY - 2001 DA - 2001// TI - Enbrel (etanercept) in patients with psoriatic arthritis and psoriasis (poster) JO - Ann Rheum Dis VL - 60 ID - Mease2001 ER - TY - JOUR AU - Mease, P. J. AU - Kivitz, A. J. AU - Burch, F. X. AU - Siegel, E. L. AU - Cohen, S. B. AU - Ory, P. AU - Salonen, D. AU - Rubenstein, J. AU - Sharp, J. T. AU - Tsuji, W. PY - 2004 DA - 2004// TI - Etanercept Treatment of Psoriatic Arthritis: Safety, Efficacy, and Effect on Disease Progression JO - Arthritis Rheum VL - 50 UR - https://doi.org/10.1002/art.20335 DO - 10.1002/art.20335 ID - Mease2004 ER - TY - JOUR AU - Salvarani, C. AU - Cantini, F. AU - Olivieri, I. PY - 2003 DA - 2003// TI - Efficacy of infliximab in resistant psoriatic arthritis JO - Arthritis Rheum VL - 49 UR - https://doi.org/10.1002/art.11201 DO - 10.1002/art.11201 ID - Salvarani2003 ER - TY - JOUR AU - Ogilvie, A. L. AU - Antoni, C. AU - Dechant, C. PY - 2001 DA - 2001// TI - Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate JO - Br J Dermatol VL - 144 UR - https://doi.org/10.1046/j.1365-2133.2001.04089.x DO - 10.1046/j.1365-2133.2001.04089.x ID - Ogilvie2001 ER - TY - JOUR AU - Van den Bosch, F. AU - Kruithof, E. AU - Baeten, D. PY - 2000 DA - 2000// TI - Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study JO - Ann Rheum Dis VL - 59 UR - https://doi.org/10.1136/ard.59.6.428 DO - 10.1136/ard.59.6.428 ID - Van den Bosch2000 ER - TY - CHAP AU - Antoni, C. AU - Kavanaugh, A. AU - Kirkham, B. PY - 2003 DA - 2003// TI - The one-year results of the infliximab multinational psoriatic arthritis controlled trial BT - Arthritis Rheum ID - Antoni2003 ER - TY - JOUR AU - Van den Bosch, F. AU - Kruithof, E. AU - Baeten, D. PY - 2002 DA - 2002// TI - Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.511 DO - 10.1002/art.511 ID - Van den Bosch2002 ER - TY - JOUR AU - Antoni AU - Krueger AU - De, V. l. a. m. AU - Birbara AU - Beutler AU - Guzzo AU - Zhou AU - Dooley AU - Kavanaugh PY - 2005 DA - 2005// TI - Infliximab Improves Signs and Symptoms of Psoriatic Arthritis: Results of the IMPACT 2 Trial JO - Ann Rheum Dis VL - 000 ID - Antoni2005 ER - TY - JOUR AU - van der Heijde, D. AU - Kavanaugh, A. AU - Beutler, A. AU - Guzzo, C. AU - Zhou, B. AU - Dooley, L. AU - Antoni, C. E. AU - Krueger, G. G. AU - Gladman, D. PY - 2005 DA - 2005// TI - Infliximab Inhibits Progression of Radiographic Damage in Patients With Active Psoriatic Arthritis: Results for Impact 2 Trial JO - Ann Rheum Dis VL - 64 ID - van der Heijde2005 ER - TY - JOUR AU - Antoni, C. E. AU - Kavanaugh, A. AU - Gladman, D. AU - Wassenberg, S. AU - Zhou, B. AU - Beutler, A. AU - Bermester, G. AU - Furst, D. E. AU - Weisman, M. AU - Ebner, W. AU - Kalden, J. R. AU - Smolen, J. AU - van der Heijde, D. PY - 2005 DA - 2005// JO - Ann Rheum Dis VL - 64 ID - Antoni2005 ER - TY - STD TI - Mease P, Gladman D, Ritchlin C, Ruderman E, Steinfeld S, Choy E, Perdok R, Weinberg M: Adalimumab Therapy in Patients with Psoriatic Arthritis: 24-week Results of a Phase III Study. Arthritis Rheum. 2004, 4097-50 ID - ref70 ER - TY - JOUR AU - Mease, P. J. AU - Sharp, J. I. AU - Ory, P. AU - Gladman, D. D. AU - Ritchlin, C. T. AU - Choy, E. H. AU - Weinberg, E. H. PY - 2005 DA - 2005// TI - Adalimumab Treatment Effects on Radiographic Progression of Joint Disease in Patients with Psoriatic Arthritis: Result from ADEPT JO - Ann Rheum Dis VL - 64 ID - Mease2005 ER - TY - JOUR AU - Weinberg, J. M. PY - 2003 DA - 2003// TI - An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80313-2 DO - 10.1016/S0149-2918(03)80313-2 ID - Weinberg2003 ER - TY - JOUR AU - Ellis, C. N. AU - Krueger, G. G. PY - 2001 DA - 2001// TI - Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJM200107263450403 DO - 10.1056/NEJM200107263450403 ID - Ellis2001 ER - TY - JOUR AU - Kraan, M. C. AU - van Kuijk, A. W. R. AU - Dinant, H. J. PY - 2002 DA - 2002// TI - Alefacept treatment in psoriatic arthritis. Reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10543 DO - 10.1002/art.10543 ID - Kraan2002 ER - TY - JOUR AU - Mease, P. AU - Gladman, D. AU - Keystone, E. PY - 2005 DA - 2005// TI - Efficacy of Alefacept in Combination with Methotrexate in the Treatment of Psoriatic Arthritis JO - Ann Rheum Dis VL - 64 ID - Mease2005 ER - TY - JOUR AU - Gladman, D. AU - Mease, P. AU - Keystone, E. PY - 2005 DA - 2005// TI - Safety of Alefacept in Combination with Methotrexate in the Treatment of Psoriatic Arthritis JO - Ann Rheum Dis VL - 64 ID - Gladman2005 ER - TY - JOUR AU - Leonardi AU - Papp AU - Gordon AU - Menter AU - Feldman AU - Cato AU - Walicke AU - Compton AU - Gottlieb PY - 2005 DA - 2005// TI - Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial JO - J Am Acad Dermatol VL - 52 UR - https://doi.org/10.1016/j.jaad.2004.09.029 DO - 10.1016/j.jaad.2004.09.029 ID - Leonardi2005 ER - TY - JOUR AU - Menter AU - Gordon AU - Carey AU - Hamilton AU - Glazer AU - Caro AU - Li AU - Gulliver PY - 2005 DA - 2005// TI - Efficacy and Safety Observed During 24 Weeks of Efalizumab Therapy in Patients with Moderate to Severe Plaque Psoriasis JO - Arch Dermatol VL - 141 UR - https://doi.org/10.1001/archderm.141.1.31 DO - 10.1001/archderm.141.1.31 ID - Menter2005 ER - TY - STD TI - [http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=7287] UR - http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=7287 ID - ref79 ER - TY - JOUR AU - Barker, J. N. AU - Jones, M. L. AU - Mitra, R. S. PY - 1991 DA - 1991// TI - Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes JO - Am J Pathol VL - 139 ID - Barker1991 ER - TY - JOUR AU - Singri, P. AU - West, D. P. AU - Gordon, K. B. PY - 2002 DA - 2002// TI - Patterns of cytokine production in psoriatic synovium JO - Arch Dermatol VL - 138 ID - Singri2002 ER - TY - JOUR AU - Bresnihan, B. AU - Cunnane, G. PY - 1998 DA - 1998// TI - Interleukin-1 receptor antagonist JO - Rheum Dis Clin North Am VL - 24 UR - https://doi.org/10.1016/S0889-857X(05)70029-6 DO - 10.1016/S0889-857X(05)70029-6 ID - Bresnihan1998 ER - TY - JOUR AU - Ritchlin, C. AU - Haas-Smith, S. A. AU - Hicks, D. PY - 1998 DA - 1998// TI - Patterns of cytokine production in psoriatic synovium JO - J Rheum VL - 25 ID - Ritchlin1998 ER - TY - JOUR AU - Reich, K. AU - Garbe, C. AU - Blaschke, V. PY - 2001 DA - 2001// TI - Response of psoriasis to interleukin-10 is associated with suppression of cutaneous type 1 inflammation, downregulation of epidermal interleukin-8/CXCR2 pathway and normalization of keratinocyte maturation JO - J Invest Dermatol VL - 116 UR - https://doi.org/10.1046/j.1523-1747.2001.01248.x DO - 10.1046/j.1523-1747.2001.01248.x ID - Reich2001 ER - TY - JOUR AU - McInnes, I. B. AU - Illei, G. G. AU - Danning, C. L. PY - 2001 DA - 2001// TI - IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis JO - J Immunol VL - 167 UR - https://doi.org/10.4049/jimmunol.167.7.4075 DO - 10.4049/jimmunol.167.7.4075 ID - McInnes2001 ER - TY - JOUR AU - Trepicchio, W. L. AU - Ozawa, M. AU - Walter, I. B. PY - 1999 DA - 1999// TI - Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions JO - J Clin Invest VL - 104 UR - https://doi.org/10.1172/JCI6910 DO - 10.1172/JCI6910 ID - Trepicchio1999 ER - TY - JOUR AU - Krueger, J. G. AU - Walters, I. B. AU - Miyazawa, M. PY - 2000 DA - 2000// TI - Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis JO - J Am Acad Dermatol VL - 43 UR - https://doi.org/10.1067/mjd.2000.106515 DO - 10.1067/mjd.2000.106515 ID - Krueger2000 ER - TY - JOUR AU - Utset, T. O. AU - Auger, J. A. AU - Peace, D. PY - 2002 DA - 2002// TI - Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial JO - J Rheum VL - 29 ID - Utset2002 ER - TY - JOUR AU - Abrams, J. R. AU - Kelley, S. L. AU - Hayes, E. PY - 2000 DA - 2000// TI - Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-Immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells JO - J Exp Med VL - 192 UR - https://doi.org/10.1084/jem.192.5.681 DO - 10.1084/jem.192.5.681 ID - Abrams2000 ER - TY - JOUR AU - Gottlieb, A. AU - Kang, S. AU - Linden, K. AU - Lebwohl, M. AU - Menter, A. AU - Abdulghani, A. AU - Goldfrab, M. AU - Cheiffo, N. AU - Tortoritis PY - 2004 DA - 2004// TI - Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis JO - Clin Imm VL - 111 UR - https://doi.org/10.1016/j.clim.2004.01.006 DO - 10.1016/j.clim.2004.01.006 ID - Gottlieb2004 ER -